Email This Press Releases

NASDAQ: BTAI Investor Notice Lawsuit Alleges Securities Laws Violations by BioXcel Therapeutics, Inc.

An investor, who purchased shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI), filed a lawsuit over alleged violations of Federal Securities Laws by BioXcel Therapeutics, Inc.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy